1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow CER-1236: new trials by email Literature Review of CER-1236 trials Research Report on CER-1236
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF) CER-1236, Cyclophosphamide, Fludarabine - AML, Acute Myeloid Leukemia | Phase 1 | Recruiting | CERo Therapeutics Holdings, Inc. | 18 | 2025-04-07 | 2026-10-21 |
CERo Therapeutics Holdings, Inc. (1)
United States (1)